Pharmaceutical customers
Revenue Exposure
Pharmaceutical and life science industries are the most significant end-use markets for HPLC; double-digit 2025 chemistry growth attributed to pharma uptake of columns and testing kits
Relevance 85·Dependency 70·Confidence 95
Source evidence
“The most significant end-use markets for HPLC are those served by the pharmaceutical and life science industries”
China's volume-based procurement, competitive bidding, and price regulation directly pressure Waters' revenues and average selling prices.
Relevance 85·Dependency 60·Confidence 90
Source evidence
“price regulation (such as volume-based procurement programs), government imposed payback provisions, and changes in reimbursement practices and policies on average selling prices for the Company’s products, which unfavorably impact the Company’s revenues”
The BDS Business was acquired from BD via Reverse Morris Trust; BD provides transition services and restrictions apply to the Company and SpinCo; integration risk and assumed indebtedness are key risks
Relevance 80·Dependency 70·Confidence 90
Source evidence
“On July 13, 2025, the Company entered into an Agreement and Plan of Merger ... by and among the Company, BD, SpinCo and Beta Merger Sub, Inc.”
Recurring revenues (consumables and service)
Revenue Exposure
Recurring revenues (precision chemistry consumables plus service) grew 8% in 2025 and provide a resilient base against instrument cyclicality
Relevance 80·Dependency 70·Confidence 96
Source evidence
“Recurring revenues (combined sales of precision chemistry consumables and services) increased 8% and 5% in 2025 and 2024, respectively”
FDA and similar foreign regulatory agencies
Regulatory Exposure
FDA and foreign regulators govern product design, manufacturing, labeling, and distribution; failure to comply could result in recalls, fines, or operational restrictions.
Relevance 80·Dependency 65·Confidence 95
Source evidence
“A portion of the Company’s operations are subject to regulation by the FDA and similar foreign regulatory agencies.”
Worldwide ERP system
Technology Dependency
Waters' ERP system is integral to books, records, transactions, and coordinating global manufacturing; disruption or failed ERP replacement could materially harm operations.
Relevance 75·Dependency 70·Confidence 90
Source evidence
“Our worldwide enterprise resource planning (“ERP”) system is integral to our ability to accurately and efficiently maintain our books and records, record transactions, coordinate resource allocation between our manufacturing facilities across the globe”
US and international manufacturing facilities
Manufacturing Dependency
Certain product lines are manufactured in one or a few concentrated plants; prolonged disruption could harm sales and may not be replaceable at other sites or third parties.
Relevance 75·Dependency 65·Confidence 90
Source evidence
“In some instances, the Company may not be able to transition manufacturing to other sites or a third party to replace the lost production.”
China is a disclosed major geography with volatile demand: sales fell 10% in 2024 on regulation and weak macro spending, then grew 10% in 2025
Relevance 75·Dependency 45·Confidence 95
Source evidence
“a 15% decrease in China instrument sales”
Agilent Technologies, Inc.
Competitive Exposure
Agilent is a principal competitor in Waters instrument markets and in consumable columns
Relevance 75·Dependency 40·Confidence 90
Source evidence
“the Company's principal competitors include: Agilent Technologies, Inc., Shimadzu Corporation, Bruker Corporation, Danaher Corporation and Thermo Fisher Scientific Inc.”
Danaher Corporation
Competitive Exposure
Danaher competes in Waters instrument markets and consumable products, and in BDS markets
Relevance 75·Dependency 40·Confidence 90
Source evidence
“In recent years, the Company's principal competitors for consumable products have included: Danaher Corporation, Merck KGaA, Agilent Technologies, Inc., General Electric Company and Thermo Fisher Scientific Inc.”
BDS acquisition financing leverage
Legal Exposure
Assumption of $4.0B SpinCo debt including a 364-day $3.5B tranche requiring refinancing creates near-term financing dependency
Relevance 70·Dependency 60·Confidence 93
Source evidence
“SpinCo borrowed $4.0 billion of unsecured term loans under the SpinCo Credit Agreement”
Singapore
Supplier Dependency
LC instrument systems and components manufacturing is outsourced to contract manufacturing firms in Singapore; the Singapore entity manages all Asian outsourced manufacturing and distribution
Relevance 70·Dependency 55·Confidence 90
Source evidence
“the Company outsources the manufacturing of certain LC instrument systems and components to well-established contract manufacturing firms in Singapore”
Tariffs / trade policy
Geopolitical Exposure
US tariffs, retaliatory tariffs and China export restrictions on manufacturing components could significantly affect operations and cash flows
Relevance 70·Dependency 50·Confidence 94
Source evidence
“These tariffs, any resulting retaliatory tariffs and any related supply-chain disruptions could have a significant impact on the Company’s consolidated statement of operations and statement of cash flows”
Group purchasing organizations
Customer Exposure
GPOs and integrated health delivery networks concentrate customer purchasing decisions, driving downward pricing pressure on Waters products.
Relevance 70·Dependency 50·Confidence 90
Source evidence
“Group purchasing organizations and integrated health delivery networks have also served to concentrate purchasing decisions for some customers, which has led to downward pricing pressures.”
Government research funding
Demand Driver
Reductions in customers' research budgets or government funding may adversely affect demand for Waters products
Relevance 65·Dependency 45·Confidence 85
Source evidence
“Reductions in customers' research budgets or government funding may adversely affect the Company's business.”
Interest rates
Demand Driver
Customer demand in certain businesses depends on capital spending budgets and interest rates, linking monetary conditions to Waters order volumes.
Relevance 65·Dependency 45·Confidence 85
Source evidence
“demand depends on customers’ capital spending budgets, government funding policies and interest rates”
EU data protection regulation
Regulatory Exposure
EU privacy regulation carries fines based on a percentage of global revenues and raises compliance costs; regulators focus on AI, biometrics, and surveillance technologies.
Relevance 65·Dependency 45·Confidence 90
Source evidence
“has enacted a broad data protection regulation with fines based on a percentage of global revenues”
United States
Revenue Exposure
Approximately 39% of the Company's employees are located in the United States
Relevance 60·Dependency 50·Confidence 90
Source evidence
“approximately 39% of the Company's employees located in the United States”
Artificial intelligence / generative AI
Competitive Exposure
Waters is integrating AI including generative AI into operations and products; execution failures could hurt competitiveness if competitors advance faster, and evolving AI regulation adds compliance burden.
Relevance 60·Dependency 40·Confidence 85
Source evidence
“Delays or disruptions in successfully developing and implementing AI as part of the Company’s business activities, products or services could have a negative impact on the Company’s competitiveness”
International operations / FX fluctuation
Currency Exposure
International operations may be negatively affected by foreign currency fluctuation, political events and regulatory changes
Relevance 60·Dependency 40·Confidence 85
Source evidence
“The Company's international operations may be negatively affected by political events, wars or terrorism, economic conditions, foreign currency fluctuation and regulatory changes”
Supply chain / manufacturing components
Cost Driver
China imposed tariffs and export restrictions on certain manufacturing components, affecting the Company's supply chain planning and cost structure
Relevance 55·Dependency 45·Confidence 85
Source evidence
“tariffs and export restrictions on certain manufacturing components imposed by China”
Foreign currency translation
Revenue Exposure
FX translation reduced sales growth by 1% in 2024 and lowered 2024 operating income by approximately $43 million
Relevance 55·Dependency 40·Confidence 90
Source evidence
“the negative effect of foreign currency translation lowered operating income by approximately $43 million during 2024”
US government research funding
Demand Driver
Customers include FDA, EPA, universities and government agencies; agency downsizing and canceled/delayed grants threaten demand
Relevance 55·Dependency 35·Confidence 88
Source evidence
“the cancellation or delay of government contracts and research grants”